All News

    Advances in surgical techniques and targeted therapies for Pancreatic Cancer

    May 1st 2025, 7:40pm

    Article

    Pancreatic cancer is one of the most challenging cancers to treat.

    Endoscopic Procedure Removes GIST Without Surgery

    May 1st 2025, 7:00pm

    Article

    A new endoscopic tunneling method, STER, allowed a patient to have a GIST removed without surgery, allowing quicker recovery and fewer complications.

    Teddy Bears Are a Good Therapy for Adults With Cancer

    May 1st 2025, 5:00pm

    Article

    Teddy bears offer emotional comfort and connection for adults with cancer, easing anxiety and fostering trust during treatment.

    In Vivo CD19 CAR-T Leads to Remission in DLBCL Without Lymphodepletion

    May 1st 2025, 4:00pm

    Article

    A patient with heavily pretreated relapsed/refractory diffuse large B-cell lymphoma achieved complete remission following novel in vivo CD19 CAR-T therapy.

    First Patient Dosed in Trial of Ziftomenib for Advanced GIST

    May 1st 2025, 3:03pm

    Article

    A phase 1 trial has initiated and is investigating treatment with ziftomenib plus Gleevec in advanced GIST following progression on Gleevec.

    BRAF Inhibitor Gel Improves Acne-Like Skin Rashes in Colorectal Cancer

    May 1st 2025, 1:00pm

    Article

    LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, according to UCLA researchers.

    The Impact of Breast Cancer on Self-Image

    May 1st 2025, 1:00pm

    Article

    A breast cancer diagnosis brings about many losses.

    FDA Completes Review of Hepzato Combo in HER2– Metastatic Breast Cancer

    April 30th 2025, 9:00pm

    Article

    The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant metastatic breast cancer.

    Patient and Disease-Related Factors Influence Outcomes in Urothelial Cancer

    April 30th 2025, 8:00pm

    Video

    Patient and disease-related factors influence surgical recovery and treatment outcomes after Keytruda and Padcev in advanced urothelial cancer.

    Aidixi Plus Bacillus Calmette-Guérin Effective in Bladder Cancer

    April 30th 2025, 7:00pm

    Article

    Aidixi plus BCG showed strong early efficacy and manageable safety in patients with high-risk, HER2-expressing non–muscle-invasive bladder cancer.